ARKO (NASDAQ:ARKO) reported quarterly sales of $1.97 billion which beat the analyst consensus estimate of $1.93 billion by 2.18 percent. This is a 32.88 percent increase over sales of $1.48 billion the same period last year.
Medtronic Announces First Patient Enrolled In U.S. Clinical Trial For Hugo Robotic-assisted Surgery System
Medtronic plc (NYSE:MDT), a global healthcare technology leader, today announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo™ robotic-assisted surgery (RAS) system. The
